Spexis AG SPEX.SW Stock
Spexis AG Price Chart
Spexis AG SPEX.SW Financial and Trading Overview
| Spexis AG stock price | 0.07 CHF |
| Previous Close | 0.4 CHF |
| Open | 0.38 CHF |
| Bid | 0.38 CHF x N/A |
| Ask | 0 CHF x N/A |
| Day's Range | 0.38 - 0.44 CHF |
| 52 Week Range | 0.3 - 1.12 CHF |
| Volume | 27.42K CHF |
| Avg. Volume | 20.21K CHF |
| Market Cap | 18.61M CHF |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.25 CHF |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.8 CHF |
SPEX.SW Valuation Measures
| Enterprise Value | 23.75M CHF |
| Trailing P/E | N/A |
| Forward P/E | -1.3448275 |
| PEG Ratio (5 yr expected) | 0.31 |
| Price/Sales (ttm) | 12.614247 |
| Price/Book (mrq) | 0.97989947 |
| Enterprise Value/Revenue | 16.099 |
| Enterprise Value/EBITDA | -1.32 |
Trading Information
Spexis AG Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -61.38% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.12 CHF |
| 52 Week Low | 0.3 CHF |
| 50-Day Moving Average | 0.38 CHF |
| 200-Day Moving Average | 0.43 CHF |
SPEX.SW Share Statistics
| Avg. Volume (3 month) | 20.21K CHF |
| Avg. Daily Volume (10-Days) | 48.16K CHF |
| Shares Outstanding | 47.71M |
| Float | 29.99M |
| Short Ratio | N/A |
| % Held by Insiders | 54.41% |
| % Held by Institutions | 1.14% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1265.40% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -29.19% |
| Return on Equity (ttm) | -74.77% |
Income Statement
| Revenue (ttm) | 1.48M CHF |
| Revenue Per Share (ttm) | 0.03 CHF |
| Quarterly Revenue Growth (yoy) | 277777.10% |
| Gross Profit (ttm) | 1.48M CHF |
| EBITDA | -17989620 CHF |
| Net Income Avi to Common (ttm) | -18553002 CHF |
| Diluted EPS (ttm) | -0.38 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.8M CHF |
| Total Cash Per Share (mrq) | 0.04 CHF |
| Total Debt (mrq) | 6.04M CHF |
| Total Debt/Equity (mrq) | 31.13 CHF |
| Current Ratio (mrq) | 0.514 |
| Book Value Per Share (mrq) | 0.398 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -11955381 CHF |
| Levered Free Cash Flow (ttm) | -8488946 CHF |
Profile of Spexis AG
| Country | Switzerland |
| State | N/A |
| City | Allschwil |
| Address | Hegenheimermattweg 125 |
| ZIP | 4123 |
| Phone | 41 61 567 16 00 |
| Website | https://spexisbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 28 |
Spexis AG, a clinical-stage biopharmaceutical company, engages in discovering, developing, in-licensing, and acquiring molecules for rare diseases and cancer. Its products pipeline includes ColiFin, an inhaled colistimethate sodium product that is in the phase 3 trial for the treatment of cystic fibrosis (CF) infections; Inhaled Murepavadin, a novel class inhaled antibiotic which is in the phase 1 development stage to treat Pseudomonas aeruginosa infection in people with CF; EBX-002 for non-tuberculous mycobacterial lung infections; Balixafortide for oncology and non-oncology indications; New CXCR4 for treating orphan and hematological malignancies, and non-oncology indications; and Outer Membrane Protein Targeting Antibiotic BamA and lipopolysaccharide transport protein A programs. Spexis AG is headquartered in Allschwil, Switzerland.
Q&A For Spexis AG Stock
What is a current SPEX.SW stock price?
Spexis AG SPEX.SW stock price today per share is 0.07 CHF.
How to purchase Spexis AG stock?
You can buy SPEX.SW shares on the Swiss exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Spexis AG?
The stock symbol or ticker of Spexis AG is SPEX.SW.
Which industry does the Spexis AG company belong to?
The Spexis AG industry is Biotechnology.
How many shares does Spexis AG have in circulation?
The max supply of Spexis AG shares is 67.66M.
What is Spexis AG Price to Earnings Ratio (PE Ratio)?
Spexis AG PE Ratio is now.
What was Spexis AG earnings per share over the trailing 12 months (TTM)?
Spexis AG EPS is -0.25 CHF over the trailing 12 months.
Which sector does the Spexis AG company belong to?
The Spexis AG sector is Healthcare.
Spexis AG SPEX.SW included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| SPI TR SSHI | 15051.28 CHF 17125.13 USD |
-0.5
|
— — | 15030.9 CHF 17101.95 USD | 15256.93 CHF 17359.12 USD | — - | — — |
- {{ link.label }} {{link}}